Hematology TimesCHMP recommends new indication for daratumumabFebruary 25, 2017Multiple MyelomaPharmacy
Hematology TimesDrug granted orphan status for follicular lymphomaFebruary 24, 2017Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesEuropean Commission approves rituximab biosimilarFebruary 23, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesGroup ranks TKIs according to cardiotoxicityFebruary 17, 2017Leukemia, Myelodysplasia, TransplantationPharmacyRelated IssuesALLCML
Hematology TimesFDA approves IVIG product for PI and chronic ITPFebruary 9, 2017AnemiaThrombosisPharmacy
Hematology TimesTherapy granted PIM designation for CTCLFebruary 3, 2017Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesCompany withdraws MAA for pegfilgrastim biosimilarFebruary 2, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyRelated Issues
Hematology TimesCheap manufacture of generic cancer drugs is feasible, study showsFebruary 2, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersHematology NursingPediatricsPharmacyRelated Issues
Hematology TimesRecent price hikes for generic cancer meds exceed 100%February 1, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyRelated Issues
Hematology TimesCHMP recommends hybrid drug for ALL, other disordersJanuary 31, 2017Leukemia, Myelodysplasia, TransplantationPharmacyALL
Hematology TimesCombo granted orphan designation for DLBCLJanuary 27, 2017Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesHealth Canada expands indication for lenalidomideJanuary 25, 2017Multiple MyelomaPharmacy
Hematology TimesFDA approves ibrutinib to treat rel/ref MZLJanuary 20, 2017Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive Lymphomas
